|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.4 CNY | +0.18% |
|
-4.15% | -24.60% |
Hubei Biocause Heilen Pharmaceutical Co., Ltd. approved final cash dividend of CNY 4.00000000 per 10 shares (tax included) for the year 2022 at its Annual General Meeting of 2022 held on May 19, 2023. Record date is 30 May 2023. Ex-date is 31 May 2023.
Payment date is 31 May 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.60% | 652M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO., LTD. 
